Search Results

FDA Raises The Status On Defective Insulin Pump Recall April 9, 2013 The U.S. Food and Drug Administration has bumped the voluntary recall on Animas 2020 Insulin infusion pumps to a Class I status. This means use of the Defective Medical Device could result in serious injury or death. According to an article from Medpage Today, the recall affects all pumps that were manufactured (more...)